HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: dc07-0098v1 30/9/2236    most recent Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Blevins, S. M. Articles by Aston, C. E. Search for Related Content PubMed PubMed Citation Articles by Blevins, S. M. Articles by Aston, C. E. Social Bookmarking                What's this?

Effect of Cinnamon on Glucose and Lipid Levels in Non–Insulin-Dependent Type 2 Diabetes

¹ Department of Medicine, University of Oklahoma, Oklahoma City, Oklahoma
² Department of Nutritional Sciences, University of Oklahoma, Oklahoma City, Oklahoma
³ Department of Geriatrics, University of Oklahoma, Oklahoma City, Oklahoma
⁴ Veterans Affairs Medical Center, Oklahoma City, Oklahoma
⁵ Arthritis and Immunology Program, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma
⁶ Department of Pediatrics, University of Oklahoma, Oklahoma City, Oklahoma

Address correspondence and reprint requests to Steve Blevins, MD, General Clinical Research Center, O'Donoghue Research Building, 1122 NE 13th St., Suite 150, Oklahoma City, OK 73104. E-mail: steve-blevins@ouhsc.edu

The first 20% of the full text of this article appears below.

	INTRODUCTION

 
Interest in cinnamon as a potentially useful treatment for type 2 diabetes began with the discovery almost 20 years ago of cinnamon's insulin-sensitizing properties (1). Numerous in vitro and in vivo studies have elucidated cinnamon's effect on insulin signal transduction (2–6). A study in diabetic mice showed that cinnamon lowered blood glucose, total cholesterol, and triglyceride levels while raising HDL cholesterol levels (7).

The first clinical trial to evaluate the effect of cinnamon in individuals with type 2 diabetes was conducted in Pakistan (8). It showed that cinnamon powder (Cinnamomum cassia), taken over a 40-day period, reduced mean fasting serum glucose (18–29%), triglyceride (23–30%), LDL cholesterol (7–27%), and total cholesterol (12–26%) levels. Three different doses of cinnamon were administered: 1, 3, and 6 g daily. All were equally effective. These findings led to widespread cinnamon use, although no study had yet evaluated the effects of cinnamon in Western diabetic populations with likely differences in diet, BMI, baseline glucose levels, and prescribed medication. We report the first U.S. study examining the effects of cinnamon on glucose and lipid levels in subjects with type 2 diabetes.

	RESEARCH DESIGN AND METHODS—

 
Participants were recruited through e-mail announcements to campus employees and through an article in the local newspaper. Individuals of any age . . . [Full Text of this Article]

	RESULTS—

 

	CONCLUSIONS—

 

CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				W. L. Baker, G. Gutierrez-Williams, C. M. White, J. Kluger, and C. I. Coleman Effect of Cinnamon on Glucose Control and Lipid Parameters Diabetes Care, January 1, 2008; 31(1): 41 - 43. [Abstract] [Full Text] [PDF]

				Cinnamon Offers No Benefit in Diabetes DOC News, November 1, 2007; 4(11): 15 - 15. [Full Text]